Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel anxiolytic and antidepressant buspirone analogue characterized

June 27, 1997

MS&D reports another series of potent and selective 5-HT1D agonists

June 27, 1997

NMDA antagonists improve memory deficits after brain injury in the rat

June 26, 1997

Univ. of Tokyo scientists isolate potent and selective papain inhibitor

June 26, 1997

Efficacy of SB-206284A in animal models of cerebral ischemia

June 26, 1997

MS&D prepares potent and selective 5-HT1D agonists

June 26, 1997

Selective dopamine D3 receptor ligands from Novo Nordisk

June 26, 1997

P&U prepares inhibitors of kynurenine 3-hydroxylase for neurodegenerative diseases

June 26, 1997

Novel melatonergic agents described by Bristol-Myers Squibb

June 26, 1997

Naratriptan highlighted at headache congress; introduced in U.K.

June 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...